Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Martini

Showing results (411-420 of 548) with videos related to

Pageof 55
Sort By:
European Urology|July 6, 2019
Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial CancerLi Wang, Yixuan Gong, Abdel Saci, et al.
The Journal of Urology|December 20, 2018
Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Phenotypic and Transcriptomic LevelAlp Tuna Beksac, Shivaram Cumarasamy, Ugo Falagario, et al.
Arthritis Care & Research|January 29, 2023
Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III StudyNicolino Ruperto, Daniel J Lovell, Alberto Berman, et al.
Pediatric Rheumatology Online Journal|December 29, 2017
Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter studyNicolino Ruperto, Hermine I Brunner, Zbigniew Zuber, et al.
Arthritis Care & Research|December 17, 2013
Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritisFriederike Rothmund, Joachim Gerss, Nicolino Ruperto, et al.
World Journal of Urology|November 7, 2022
Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimensAlberto Martini, Alae Touzani, Jean-Baptiste Beauval, et al.
European Radiology|April 30, 2025
Diagnostic accuracy of multiparametric MRI for detecting unconventional prostate cancer histology: a systematic review and meta-analysisFilippo Carletti, Martina Maggi, Tamas Fazekas, et al.
European Urology Oncology|September 4, 2023
Prostate Cancer-specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years' Report from the European Association of Urology Robotic Urology Section Scientific Working GroupUgo Giovanni Falagario, Sophie Knipper, Francesco Pellegrino, et al.
Pediatric Rheumatology Online Journal|September 9, 2010
The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trialSudha Visvanathan, Carrie Wagner, Joseph C Marini, et al.
RMD Open|July 16, 2020
Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexateDaniel J Lovell, Hermine I Brunner, Andreas O Reiff, et al.
Pageof 55

Showing results (411-420 of 548) with videos related to

Sort By:
Pageof 55
European Urology|July 6, 2019
Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial CancerLi Wang, Yixuan Gong, Abdel Saci, et al.
The Journal of Urology|December 20, 2018
Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Phenotypic and Transcriptomic LevelAlp Tuna Beksac, Shivaram Cumarasamy, Ugo Falagario, et al.
Arthritis Care & Research|January 29, 2023
Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III StudyNicolino Ruperto, Daniel J Lovell, Alberto Berman, et al.
Pediatric Rheumatology Online Journal|December 29, 2017
Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter studyNicolino Ruperto, Hermine I Brunner, Zbigniew Zuber, et al.
Arthritis Care & Research|December 17, 2013
Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritisFriederike Rothmund, Joachim Gerss, Nicolino Ruperto, et al.
World Journal of Urology|November 7, 2022
Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimensAlberto Martini, Alae Touzani, Jean-Baptiste Beauval, et al.
European Radiology|April 30, 2025
Diagnostic accuracy of multiparametric MRI for detecting unconventional prostate cancer histology: a systematic review and meta-analysisFilippo Carletti, Martina Maggi, Tamas Fazekas, et al.
European Urology Oncology|September 4, 2023
Prostate Cancer-specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years' Report from the European Association of Urology Robotic Urology Section Scientific Working GroupUgo Giovanni Falagario, Sophie Knipper, Francesco Pellegrino, et al.
Pediatric Rheumatology Online Journal|September 9, 2010
The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trialSudha Visvanathan, Carrie Wagner, Joseph C Marini, et al.
RMD Open|July 16, 2020
Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexateDaniel J Lovell, Hermine I Brunner, Andreas O Reiff, et al.
Pageof 55